Home > Healthcare > Medical Devices > Therapeutic Devices > Smart Inhalers Market

Smart Inhalers Market Share

Report ID: GMI3994
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Smart Inhalers Market Share

The smart inhalers industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Novartis holds a significant share in the market. The companies are diligently directing their efforts towards continuous product innovation and partnership with other players to gain substantial market share. For instance, Novartis collaborated with Propeller Health to connect the digital health platform to enerzair breezhaler in order to treat inadequately controlled asthma patients in Europe.

Some of the eminent market participants operating in the smart inhalers industry include:

Adherium
Propeller Health
Nemera
GlaxoSmithKline Plc.
Novartis AG
Aptar Group Inc
AstraZeneca Plc
Findair Sp. Z.o.o.
BioCorp
Zeolr Technologies Pvt Ltd.
Vectura Group Plc.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global smart inhalers industry size was USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032.

COPD held over 57% industry share in 2022 and will augment the market demand by 2032 due to aging population base, rising disease prevalence caused by continued exposure to risk factors such as tobacco smoke and air pollution, coupled with improved disease diagnosis.

U.S. smart inhalers market accounted for USD 520 million in 2022 and is predicted to witness substantial growth through 2032 owing to technological advancements coupled with substantial healthcare expenditure.

Adherium, Propeller Health, Nemera, GlaxoSmithKline Plc., Novartis AG, Aptar Group Inc, AstraZeneca Plc, Findair Sp. Z.o.o., BioCorp, Zeolr Technologies Pvt Ltd., Vectura Group Plc., Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim International GmbH.